Stay updated on Avelumab in Combination with CRT Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Combination with CRT Clinical Trial page.
Latest updates to the Avelumab in Combination with CRT Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check32 days agoNo Change Detected
- Check45 days agoChange DetectedThe study has expanded to include 316 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.1%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check68 days agoChange DetectedThe value Revision: v2.9.5 has recently changed to Revision: v2.9.6. This change represents an update in the study record details and results reporting dates for a phase 3 randomized, placebo-controlled study evaluating the safety and anti-tumor activity of Avelumab in combination with standard of care chemoradiation therapy for patients with locally advanced squamous cell carcinoma of the head and neck.SummaryDifference0.0%
- Check73 days agoChange DetectedThe value Revision: v2.9.3 has recently changed to Revision: v2.9.5. This change represents an update in the study record details and results reporting dates for the clinical trial involving Avelumab in combination with standard-of-care chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck.SummaryDifference0.0%
Stay in the know with updates to Avelumab in Combination with CRT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Combination with CRT Clinical Trial page.